Fibrin(ogen) may be an important target for methylglyoxal-derived AGE modification in elastic arteries of humans

Diabetes and Vascular Disease Research

Volumn 8, Issue 4, 2011, Pages 284-294

  Lund, Terje ^a   Svindland, Aud ^b   Pepaj, Milaim ^a   Jensen, Aase Brith ^a   Berg, Jens P ^b   Kilhovd, Bente ^b   Hanssen, Kristian F ^b,c  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

advanced glycation end products; atherosclerosis; diabetes; fibrin; methylglyoxal

Indexed keywords

ADVANCED GLYCATION END PRODUCT; FIBRINOGEN; HYDROIMIDAZOLONE; IMIDAZOLE DERIVATIVE; LAMIN A; LAMIN C; METHYLGLYOXAL; MOESIN; UNCLASSIFIED DRUG;

ADULT; AGED; AORTA; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD VESSEL WALL; CAROTID ARTERY; CELL NUCLEUS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROVASCULATURE; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; AORTA; BLOTTING, WESTERN; CAROTID ARTERY, COMMON; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; DIABETIC ANGIOPATHIES; ELASTICITY; FEMALE; FIBRIN; FIBRINOGEN; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NECROSIS; NORWAY; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; PYRUVALDEHYDE; TANDEM MASS SPECTROMETRY;

EID: 80053070121     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164111416831     Document Type: Article

References (39)

1. Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in the middle-aged subjects. Diabetes Care. 2008 ; 31: 714-719
2. Peppa M, Uribarri J, Vlassara H. The role of advanced glycation end-products in the development of atherosclerosis. Curr Diab Rep. 2004 ; 4: 31-36 (Pubitemid 39359508)
3. Calcutt NA, Cooper ME, Kern TS, Schmidt AM. Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. Nat Rev Drug Discov. 2009 ; 8: 417-429
4. Kilhovd BK, Juutilainen A, Lehto S, et al. Increased serum levels of advanced glycation endproducts predicts total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study. Diabetologia. 2007 ; 50: 1409-1417 (Pubitemid 46879016)
5. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001 ; 44: 1521-1528
6. Schalkwijk CG, van Bezu J, van der Schors RC, et al. Heat-shock protein 27 is a major methylglyoxal-modified protein in endothelial cells. FEBS Lett. 2006 ; 580: 1565-1570 (Pubitemid 43290351)
7. McLellan AC, Thornalley PJ, Benn J, Sonksen PH. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci (Lond). 1994 ; 87: 21-29 (Pubitemid 24220267)
8. Wang H, Meng QH, Gordon JR, Khandwala H, Wu L. Proinflammatory and proapoptotic effects of methyloxal on neutrophils from patients with type 2 diabetes mellitus. Clin Biochem. 2007 ; 40: 1232-1239 (Pubitemid 47562425)
9. Thornalley PJ, Battah S, Ahmed N, et al. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J. 2003 ; 375: 581-592 (Pubitemid 37433506)
10. Brouwers O, Niessen PM, Haenen G, et al. Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia. 2010 ; 53: 989-1000
11. Rosca MG, Mustata TG, Kinter MT, et al. Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am J Physiol Renal Physiol. 2005 ; 289: F420 - F430
12. Yao D, Taguchi T, Matsumara T, et al. High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem. 2007 ; 282: 31038-31045 (Pubitemid 350035169)
13. Thangarajah H, Yao D, Chang EI, et al. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci USA. 2009 ; 106: 13505-13510
14. McClung JA, Naseer N, Saleem M, et al. Elevation of detached and circulating endothelial cells is a marker for vascular injury in patients with type 2 diabetes mellitus. Hypertension. 2004 ; 44: 564
15. Dobler D, Ahmed N, Song L, Eboigbodin KE, Thornalley PJ. Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification. Diabetes. 2006 ; 55: 1961-1969 (Pubitemid 44509968)
16. Pedchenko VK, Chetyrkin SV, Chuang P, et al. Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy. Diabetes. 2005 ; 54: 2952-2960 (Pubitemid 41401092)
17. McDonald DM, Coleman G, Bhatwadekar, Gardiner TA, Stitt AW. Advanced glycation of the Arg-Gly-Asp (RGD) tripeptide motif modulates retinal microvascular endothelial cell dysfunction. Mol Vis. 2009 ; 15: 1509-1520
18. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb. 1994 ; 14: 840-856
19. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis. Am Heart Assoc. 1995 ; 15: 1512-1531
20. Nishikawa T, Edelstein D, Xue LD, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature. 2000 ; 404: 787-790 (Pubitemid 30212409)
21. Faisal Khan KM, Laurie GW, McCaffrey TA, Falcone DJ. Exposure of cryptic domains in the alpha1-chain of laminin-1 by elastase stimulates macrophages urokinase and matrix metalloproteinase-9 expression. J Biol Chem. 2002 ; 277: 13778-13786 (Pubitemid 34967981)
22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 ; 72: 248-254
23. Olsen JV, de Godoy LM, Li G, et al. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics. 2005 ; 4: 2010-2021 (Pubitemid 41830195)
24. Koehler CJ, Strozynski M, Kozielski F, Treumann A, Thiede B. Isobaric peptide termini labeling for MS/MS-based quantitative proteomics. J Proteome Res. 2009 ; 8: 4333-4341
25. Lominadze D, Dean WL, Tyagi SC, Roberts AM. Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease. Acta Physiol (Oxf). 2010 ; 198: 1-13
26. Bini A, Fenoglio JJ, Mesa-Tejada R, Kudryk B, Kaplan KL. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis. 1989 ; 9: 109-121 (Pubitemid 19046097)
27. Tavora F, Cresswell N, Li L, Ripple M, Burke A. Immunolocalisation of fibrin in coronary atherosclerosis: implications for necrotic core development. Pathology. 2010 ; 42: 15-22
28. Zhang Y, Cliff WJ, Schoefl GI, Higgins G. Immunohistochemical study of intimal microvessels in coronary atherosclerosis. Am J Pathol. 1993 ; 143: 164-72 (Pubitemid 24058170)
29. Moreno PR, Fuster V. New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol. 2004 ; 44: 2293-2300 (Pubitemid 39647601)
30. Dejana E, Colella S, Languino LR, et al. Fibrinogen induces adhesion, spreading, and microfilament organization of human endothelial cells in vitro. J Cell Biol. 1987 ; 104: 1403-1411 (Pubitemid 17084498)
31. Pozzi A, Zent R, Chetyrkin S, et al. Modification of collagen IV by glucose or methylglyoxal alters distinct mesangial cell functions. J Am Soc Nephrol. 2009 ; 20: 2119-2125
32. Mosesson MW. Fibrin and fibrin structure and functions. J Thromb Haemost. 2005 ; 3: 1894-1904
33. Zacharowski K, Zacharowski P, Reingruber S, Petzelbauer P. Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction. J Mol Med. 2006 ; 84: 469-477 (Pubitemid 43801325)
34. Clark RA, Tonnesen MG, Gailit J, Cheresh DA. Transient functional expression of αvβ3 on vascular cells during wound repair. Am J Pathol. 1996 ; 148: 1407-1421 (Pubitemid 26135885)
35. Kluger MS. Vascular endothelial cell adhesion and signaling during leukocyte recruitment. Adv Dermatol. 2004 ; 20: 163-201 (Pubitemid 40694652)
36. Dechat T, Pfleghaar K, Sengupta K, et al. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev. 2008 ; 22: 832-853 (Pubitemid 351482836)
37. Eriksson M, Brown WT, Gordon LB, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 2003 ; 423: 293-298 (Pubitemid 40852699)
38. Nakadate Y, Uchida K, Shikata K, et al. The formation of argpyrimidine, a methylglyoxal-arginine adduct, in the nucleus of neural cells. Biochem Biophys Res Commun. 2009 ; 378: 209-212
39. Rabbani N, Thornalley PJ. Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome. Amino acids. 2010 ;: